AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 159 filers reported holding AKERO THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.15 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,281,278 | +25.6% | 183,497 | +15.9% | 0.06% | +31.0% |
| Q2 2023 | $7,389,720 | +17.4% | 158,272 | -3.8% | 0.04% | -2.3% |
| Q1 2023 | $6,293,885 | -38.8% | 164,503 | -12.4% | 0.04% | -50.0% |
| Q4 2022 | $10,291,385 | +975.4% | 187,799 | +178.4% | 0.09% | +1333.3% |
| Q1 2022 | $957,000 | -19.4% | 67,455 | +20.1% | 0.01% | 0.0% |
| Q4 2021 | $1,188,000 | +26.5% | 56,159 | +33.6% | 0.01% | 0.0% |
| Q3 2021 | $939,000 | -19.5% | 42,024 | -10.7% | 0.01% | -14.3% |
| Q2 2021 | $1,167,000 | -14.9% | 47,048 | -0.5% | 0.01% | -22.2% |
| Q1 2021 | $1,371,000 | +501.3% | 47,270 | +435.8% | 0.01% | +350.0% |
| Q4 2020 | $228,000 | – | 8,822 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skorpios Trust | 1,621,829 | $75,723,196 | 32.88% |
| COMMODORE CAPITAL LP | 1,675,000 | $78,205,750 | 8.79% |
| Ghost Tree Capital, LLC | 360,000 | $16,808,400 | 5.55% |
| Boxer Capital, LLC | 1,676,733 | $78,287 | 3.63% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 241,357 | $11,268,958 | 3.49% |
| Atlas Venture Life Science Advisors, LLC | 594,251 | $27,745,579 | 3.45% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 236,500 | $11,039,820 | 3.42% |
| Logos Global Management LP | 520,000 | $24,278,800 | 3.30% |
| Redmile Group, LLC | 1,811,672 | $84,586,966 | 3.25% |
| Yiheng Capital Management, L.P. | 1,201,591 | $56,102,284 | 3.03% |